The integration of a polyarginine cell penetrating peptide with a GRP78‐targeting peptide provides selective and effective peptide‐based siRNA transfection directly within the GRP78 overexpressing prostate cancer (DU145) cells. Here, HSPA5 is linked to prostate cancer.